hexavalent reassortant rotavirus vaccine (live attenuated) (Wuhan Institute of Biological Products)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehexavalent reassortant rotavirus vaccine (live attenuated) (Wuhan Institute of Biological Products)
Drug Alias Namerotavirus vaccine (Wuhan)
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRotavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuhan Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsRotavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A